scholarly journals In-Silico Evaluation of Glucose Regulation Using Policy Gradient Reinforcement Learning for Patients with Type 1 Diabetes Mellitus

2020 ◽  
Vol 10 (18) ◽  
pp. 6350
Author(s):  
Jonas Nordhaug Myhre ◽  
Miguel Tejedor ◽  
Ilkka Kalervo Launonen ◽  
Anas El Fathi ◽  
Fred Godtliebsen

In this paper, we test and evaluate policy gradient reinforcement learning for automated blood glucose control in patients with Type 1 Diabetes Mellitus. Recent research has shown that reinforcement learning is a promising approach to accommodate the need for individualized blood glucose level control algorithms. The motivation for using policy gradient algorithms comes from the fact that adaptively administering insulin is an inherently continuous task. Policy gradient algorithms are known to be superior in continuous high-dimensional control tasks. Previously, most of the approaches for automated blood glucose control using reinforcement learning has used a finite set of actions. We use the Trust-Region Policy Optimization algorithm in this work. It represents the state of the art for deep policy gradient algorithms. The experiments are carried out in-silico using the Hovorka model, and stochastic behavior is modeled through simulated carbohydrate counting errors to illustrate the full potential of the framework. Furthermore, we use a model-free approach where no prior information about the patient is given to the algorithm. Our experiments show that the reinforcement learning agent is able to compete with and sometimes outperform state-of-the-art model predictive control in blood glucose regulation.

1993 ◽  
Vol 10 (1) ◽  
pp. 74-80 ◽  
Author(s):  
Robert Peveler ◽  
B.A. Davies ◽  
R.A. Mayou ◽  
C.G. Fairburn ◽  
J.I. Mann

JMS SKIMS ◽  
2011 ◽  
Vol 14 (1) ◽  
pp. 33
Author(s):  
Feroze Ahmad ◽  
Shariq R Masoodi

16 year male, with type 1 diabetes mellitus for last 6 years was admitted because of Diabetic Ketoacidosis (DKA). Despite having good insulin compliance, he had lost 4 Kg over last 5 months and had HbA1c of 11.3 % at admission. On examination, he was found to have abdominal lipohypertrophy where he had been persistently injecting insulin. Injecting insulin at different sites dramatically improved blood glucose control after he was out of DKA. Insulin injections can. JMS 2011;14(1):33


2020 ◽  
Author(s):  
Stan Kriventsov ◽  
Alexander Lindsey ◽  
Amir Hayeri

BACKGROUND Diabetes mellitus, which causes dysregulation of blood glucose in humans, is a major public health challenge. Patients with diabetes must monitor their glycemic levels to keep them in a healthy range. This task is made easier by using continuous glucose monitoring (CGM) devices and relaying their output to smartphone apps, thus providing users with real-time information on their glycemic fluctuations and possibly predicting future trends. OBJECTIVE This study aims to discuss various challenges of predictive monitoring of glycemia and examines the accuracy and blood glucose control effects of Diabits, a smartphone app that helps patients with diabetes monitor and manage their blood glucose levels in real time. METHODS Using data from CGM devices and user input, Diabits applies machine learning techniques to create personalized patient models and predict blood glucose fluctuations up to 60 min in advance. These predictions give patients an opportunity to take pre-emptive action to maintain their blood glucose values within the reference range. In this retrospective observational cohort study, the predictive accuracy of Diabits and the correlation between daily use of the app and blood glucose control metrics were examined based on real app users’ data. Moreover, the accuracy of predictions on the 2018 Ohio T1DM (type 1 diabetes mellitus) data set was calculated and compared against other published results. RESULTS On the basis of more than 6.8 million data points, 30-min Diabits predictions evaluated using Parkes Error Grid were found to be 86.89% (5,963,930/6,864,130) clinically accurate (zone A) and 99.56% (6,833,625/6,864,130) clinically acceptable (zones A and B), whereas 60-min predictions were 70.56% (4,843,605/6,864,130) clinically accurate and 97.49% (6,692,165/6,864,130) clinically acceptable. By analyzing daily use statistics and CGM data for the 280 most long-standing users of Diabits, it was established that under free-living conditions, many common blood glucose control metrics improved with increased frequency of app use. For instance, the average blood glucose for the days these users did not interact with the app was 154.0 (SD 47.2) mg/dL, with 67.52% of the time spent in the healthy 70 to 180 mg/dL range. For days with 10 or more Diabits sessions, the average blood glucose decreased to 141.6 (SD 42.0) mg/dL (<i>P</i>&lt;.001), whereas the time in euglycemic range increased to 74.28% (<i>P</i>&lt;.001). On the Ohio T1DM data set of 6 patients with type 1 diabetes, 30-min predictions of the base Diabits model had an average root mean square error of 18.68 (SD 2.19) mg/dL, which is an improvement over the published state-of-the-art results for this data set. CONCLUSIONS Diabits accurately predicts future glycemic fluctuations, potentially making it easier for patients with diabetes to maintain their blood glucose in the reference range. Furthermore, an improvement in glucose control was observed on days with more frequent Diabits use. CLINICALTRIAL


Sign in / Sign up

Export Citation Format

Share Document